FreeStyle Libre 2 Cleared by FDA as iCGM

The addition of Bluetooth connectivity enables high and low blood glucose alerts; it is same size and price as the original FreeStyle Libre, and shows far better accuracy

Abbott (ABT) Gets FDA Clearance for FreeStyle Libre 3 Reader

Abbott's Freestyle® Libre 2 IOS App Cleared In U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management

2 Million Patients And Beyond: Abbott's FreeStyle Libre 2 Cleared In The U.S. For Adults And Children With Diabetes

FDA clears Abbott's FreeStyle Libre 2 and 3 sensors for integration with AID systems

Abbott FreeStyle Libre 2 iCGM FDA cleared for use in adults and children - MassDevice

FreeStyle Libre 2 iOS App is Cleared in the U.S.

Impatience Grows for Abbott's FreeStyle Libre 2 iCGM

Freestyle Libre 2 and 3 Receive FDA Clearance for Integration with Automated Insulin Delivery Systems

Abbott's FreeStyle® Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards

FreeStyle Libre 2 Cleared by FDA as iCGM

Abbott's FreeStyle® Libre 14 Day Flash Glucose Monitoring System Now Approved in the U.S. - iData Research

Abbott's FreeStyle Libre 2 iOS App Cleared in U.S., Providing a Seamles's Digital Experience to Simplify Diabetes Management

FreeStyle Libre 2 Sensor

FDA Clears App for FreeStyle Libre 2 Glucose Monitor